Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-IMG-75183

Xenbase Image ID: 75183


Figure 7. Xenopus tropicalis embryos (A–C) were injected in the two dorsal cells at the four-cell stage with the control morpholino oligonucleotide (MO; A), the X. tropicalis β-catenin MO (B), or the X. laevis β-catenin MO (C) and grown to stage 28. X. laevis embryos (D–I) were injected with the control MO (D,G), the X. tropicalis β-catenin MO (E,H), or the X. laevis β-catenin MO (F,I), and grown to stage 28. The X. laevis embryos received either a lower dose MO injection of 7.5 ng (D–F) or a higher dose MO injection of 25 ng (G–I). Embryos were fixed and immunostained for somitic muscle with 12/101 antibody. Uninjected control embryos were also fixed and stained (data not shown) and were identical to the controls in A, D, and G.Download figure to PowerPoint

Image published in: Khokha MK et al. (2002)

Copyright © 2002. Image reproduced on Xenbase with permission of the Publisher, John Wiley & Sons.

Larger Image
Printer Friendly View

Return to previous page

My Xenbase: [ Log-in / Register ]
version: [4.5.0]

Major funding for Xenbase is provided by the National Institute of Child Health and Human Development, grant P41 HD064556